KHK and metabolic dysfunction-associated steatotic liver disease: KHK deficiency or inhibition (PF-06835919) protects animals from fructose-induced obesity, insulin resistance, hypertriglyceridemia, and NAFLD (Lanaspa et al., 2013; Futatsugi et al., 2020; Gutierrez et al., 2021).